Evidence explainerFertility & Prenatal
CoQ10, Myo-Inositol and Other Fertility Supplements: What the Trials Actually Show
Cochrane reviews rate the evidence for antioxidant and inositol supplements in women trying to conceive as low to very low quality. CoQ10 looks most promising for women with a poor IVF response, and a large trial of folic acid and zinc for men found no benefit.
Key takeaways
- A Cochrane review of 63 trials (7,760 women) found low- to very low-quality evidence that antioxidants, including CoQ10 and myo-inositol, may help subfertile women, and was uncertain whether they raise live birth rates [1].
- In a 2023 network meta-analysis of 16 trials (2,323 women with poor ovarian response to IVF), CoQ10 was linked to higher clinical pregnancy (odds ratio 2.22) and live birth (odds ratio 2.36) rates than standard stimulation alone [2].
- A Cochrane review of 13 myo-inositol trials in subfertile women with PCOS rated the evidence low to very low quality [3], and the 2023 PCOS guideline calls inositol experimental therapy for infertility [4].
- In the FAZST trial of 2,370 couples, 5 mg folic acid plus 30 mg zinc for men did not improve semen quality or live births (34% vs 35%) [5].
Antioxidants for women: what Cochrane found
The 2020 Cochrane review pooled 63 trials of oral antioxidants, including CoQ10, myo-inositol, melatonin, N-acetylcysteine, vitamins and omega-3s. Because the evidence was very low quality, the authors were uncertain whether antioxidants improve live birth; low-quality evidence suggested they may improve clinical pregnancy rates, with no sign of more miscarriages [1].
In March 2026 Cochrane added an editorial note: seven included studies have since been retracted and two carry expressions of concern; the editors judged that removing them does not meaningfully change the conclusions [1]. Only 27 of the 63 trials reported their funding [1].
CoQ10 and poor ovarian response
The strongest signal for CoQ10 is in women who produce few eggs during IVF. A 2023 network meta-analysis of 16 randomized trials in 2,323 such women found CoQ10 was associated with higher clinical pregnancy and live birth rates than ovarian stimulation alone, though the confidence intervals were wide (live birth odds ratio 2.36, 95% CI 1.07 to 5.38) [2].
These are small trials in an IVF population, so they do not show that CoQ10 helps women trying to conceive naturally. See our CoQ10 monograph for forms and doses.
Myo-inositol and PCOS
A Cochrane review of 13 trials in 1,472 subfertile women with PCOS, mostly taking myo-inositol before IVF, rated the evidence low to very low quality [3]. The 2023 international PCOS guideline says inositol, alone or combined with other treatments, should be considered experimental therapy for infertility in PCOS, with benefits and risks too uncertain to recommend it as a fertility treatment [4].
Our inositol for PCOS guide covers its metabolic effects, where the evidence is somewhat better.
Supplements for men
Supplements marketed for male fertility commonly contain folic acid and zinc [5]. In FAZST, a multicenter trial of 2,370 couples planning infertility treatment, men took 5 mg folic acid and 30 mg zinc or placebo daily for 6 months. Live births did not differ (34% vs 35%), most semen measures did not change, and sperm DNA fragmentation rose slightly with the supplement (29.7% vs 27.2%) [5].
The supplement group also had more abdominal pain, nausea and vomiting [5]. The authors concluded the findings do not support folic acid and zinc for male partners in infertility treatment [5].
Quick answers
More in Fertility & Prenatal
References
- [1]Antioxidants for female subfertility (Cochrane review). Cochrane Database Syst Rev, 2020.
- [2]TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis. Reprod Biol Endocrinol, 2023.
- [3]Inositol for subfertile women with polycystic ovary syndrome (Cochrane review). Cochrane Database Syst Rev, 2018.
- [4]Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab, 2023.
- [5]Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial. JAMA, 2020.
